Toxicology and Carcinogenesis Studies of Methylene Blue Trihydrate in F344/N Rats and B6C3F1 Mice (Gavage Studies), TR-540 – abstract (2008)

Peer-Reviewed Study · National Toxicology Program (NIEHS/NIH) · May 2008

National Toxicology Program (NIEHS/NIH), 2008-05: The US National Toxicology Program's two-year study of methylene blue given by gavage to rats and mice. It records deaths at high doses, methemoglobinemia and Heinz-body anaemia, and increases in pancreatic islet tumours and intestinal carcinomas.

The incidences of pancreatic islet cell adenoma and adenoma or carcinoma (combined) were increased in all dosed groups of males

National Toxicology Program (NIEHS/NIH), 2008-05: The US National Toxicology Program's two-year study of methylene blue given by gavage to rats and mice. It records deaths at high doses, methemoglobinemia and Heinz-body anaemia, and increases in pancreatic islet tumours and intestinal carcinomas. Study type: 2-year rodent carcinogenicity bioassay with 1-month and 3-month pre-studies. N: 50 per sex per dose group in the 2-year phase. Country: USA (Southern Research Institute). Dose: rats 0, 5, 25, 50 mg/kg; mice 0, 2.5, 12.5, 25 mg/kg, 5 days/week, gavage. Route: oral gavage in 0.5% methylcellulose. Levels of evidence: male rats 'some evidence' (pancreas islet adenoma), male mice 'some evidence' (small intestine carcinoma), female mice 'equivocal evidence' (malignant lymphoma), female rats 'no evidence'. NCI nominated the compound. This is a direct record of harm at chronic oral dosing. Study type: animal.